We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug & Device Products
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Publications
    • Webinar Training Pass
    • eCFR and Guidances
    • Books
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Mevion Opens First Back-to-Back Proton Therapy Centers

Mevion Opens First Back-to-Back Proton Therapy Centers

June 8, 2015

Mevion Medical Systems’ new proton therapy center has begun treating patients, less than a month after it opened its last one, making it the first company to launch back-to-back proton centers, the Littleton, Mass., devicemaker announced Monday.

Previously, proton therapy systems have cost millions of dollars to set up, usually taking up the size of a football field. This limits patient access to these facilities because few cancer centers have the money or space to build them. However, as the world’s smallest single-room proton therapy system, the Mevion S250 helps reduce these restrictions, using up to 90 percent less energy than comparable systems, the company claims.

The installation occurred at the Robert Wood Johnson University Hospital in New Brunswick, N.J. Meanwhile, the company’s proton therapy center at Ackerman Cancer Center in Jacksonville, Fla., opened April 30, is treating 24 patients per day, the devicemaker says. That facility bears the distinction of being the first ever physician-owned proton center.

The company is installing the center at four other sites in the U.S. The system is approved for use in Europe.

Proton therapy works by targeting cancer cells, but causes less damage to surrounding healthy tissue, unlike photon radiation. This makes it a more attractive option for patients with tumors in sensitive areas, such those near the heart, brain and spine. — Jason Scott

Medical Devices Commercial Operations

Upcoming Events

  • 08Feb

    Process and Design Validation for Devicemakers: A Deep Dive into Best Practices, Recent Trends and Regulatory Definitions

  • 09Feb

    The Inextricable Link Between Data Integrity and Quality Culture

  • 15Feb

    Advanced Compliance Writing CAPA: Mastering Failure Investigation and Root Cause Analysis

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 22Feb

    Best Practices for Developing and Maintaining a GxP Training Matrix

  • 07Mar

    FDA’s Remote Assessments v. Remote Interactive Evaluations: Do You Really Know the Difference?

Featured Products

  • FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

    FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

  • Selecting and Implementing Electronic Document Management Systems in the EU

    Selecting and Implementing Electronic Document Management Systems in the EU

Featured Stories

  • MedTrace Receives U.S. Patent for Heart Modeling Method

  • NICE Recommends Epidyolex for Tuberous Sclerosis Complex Seizures

  • Consortium Gets EU Funding to Develop Continuous Blood Pressure Monitoring Device

  • FDA Approves GSK’s Oral Drug for Chronic Kidney Disease-Related Anemia

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell or Share My Data
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing